Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05521126 · ClinicalTrials.gov registry record

Micro-Doppler Radar: A Gold Standard Comparison

A clinical trial of Anterior Cruciate Ligament Injuries and Musculoskeletal Injury, sponsored by Milton S. Hershey Medical Center.

Active
Registry status
181
Enrollment target
2
Study locations

NCT05521126 is a study of Anterior Cruciate Ligament Injuries and Musculoskeletal Injury that is active but no longer recruiting, run by Milton S. Hershey Medical Center. The registered enrollment target is 181 participants, below the 316-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (43% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05521126, a study of Anterior Cruciate Ligament Injuries and Musculoskeletal Injury, is active but no longer recruiting, sponsored by Milton S. Hershey Medical Center.

ACTIVE NOT RECRUITING
Registry status
181 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to see if the study team can use micro-Doppler signal (MDS) technology to determine if someone has had an anterior cruciate ligament (ACL) reconstruction. The investigators will do this by comparing the movement data from a group of people who have had the surgery with a group who has not had the surgery to see if the micro-Doppler radar technology can accurately and predictably tell the difference.

Study Locations (2)

Pennsylvania

  • Lebanon Valley College - Annville
  • Pennsylvania State University College of Medicine - Hershey

Trial Details

FieldValue
Enrollment Target 181 participants
Start Date 2023-02-21
Est. Completion 2026-06

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT05521126

The ClinicalTrials.gov registry entry for NCT05521126 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 316-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (43% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anterior Cruciate Ligament Injuries appearing as the primary indexed condition, and to 0 interventions.

NCT05521126 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05521126 about?

NCT05521126 is a clinical study titled "Micro-Doppler Radar: A Gold Standard Comparison". The purpose of this study is to see if the study team can use micro-Doppler signal (MDS) technology to determine if someone has had an anterior cruciate ligament (ACL) reconstruction. The investigators will do this by comparing the movement data from a group of people who have had the surgery with a...

What is the current status of trial NCT05521126?

This trial is currently active not recruiting. The enrollment target is 181 participants. The study started on 2023-02-21. Estimated completion is 2026-06.

What conditions does trial NCT05521126 study?

This clinical trial studies the following conditions: Anterior Cruciate Ligament Injuries, Musculoskeletal Injury.

Who is sponsoring clinical trial NCT05521126?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05521126 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anterior Cruciate Ligament Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.